After the discovery that this compoundcould remove lipofuscin from the RPE in monkeys (Julien and Schraermeyer, 2012), its potential forthe treatment of ABCA4-associated retinopathy is now alsobeing studied, with no data reported so far. Here, ABCA4 is linked to retinal disorder.